Reported Oct 20, 2021 · Terminated

Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun…

Strides Pharma Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Strides Pharma Inc. · 2 Tower Center Blvd Ste 1102 · East Brunswick, NJ · 08816-1100

Is this the product you have?

  • Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only
  • Manufactured byStrides Shasun Limited, Bengaluru - 562106, India
  • Distributed byStrides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07
Lot codes and dates
    • Lot 7240840A
    • exp. 12/31/2021
Amount recalled
1813 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Dissolution Specifications

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Strides Pharma Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Oct 26, 2022 · Data as of Sep 19, 6:39 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.